2013 annual financial data
Supernus Pharmaceuticals 2013 Operating margin
Supernus Pharmaceuticals 2013 operating margin with verified reported values.
Direct answer
Operating margin was -515.18%.
Operating income was -61,920,000 USD and net income was -92,273,000 USD.
Operating cash flow was -57,949,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,019,000 USD
- Operating income
- -61,920,000 USD
- Net income
- -92,273,000 USD
- Operating cash flow
- -57,949,000 USD